AbstractSince 2005, the Government of the United States of America has provided more than US$ 50 million to advance influenza vaccine development in low-resourced countries. This programme has provided a unique opportunity for the US Government to develop a comprehensive view of, and to understand better the challenges and future needs for influenza vaccines in the developing world. The funding for this programme has been primarily through a cooperative agreement with the World Health Organization (WHO) to support directly its capacity-building grants to government-owned or -supported vaccine manufacturers in developing countries. A second cooperative agreement with the Program for Appropriate Technologies in Health (PATH) was initiated to ...
Vaccines have significantly reduced the detrimental effects of numerous human infectious diseases wo...
AbstractSince 2008, the World Health Organization has provided seed grants to 11 manufacturers in lo...
AbstractTechnology transfer is a promising approach to increase vaccine production at an affordable ...
Since 2005, the Government of the United States of America has provided more than US$ 50 million to ...
AbstractSince 2005, the Government of the United States of America has provided more than US$ 50 mil...
AbstractShould a highly pathogenic avian influenza virus, such as the H5N1 virus type currently circ...
It is predicted that in case of an influenza pandemic, there will be a significant gap between poten...
AbstractIt is predicted that in case of an influenza pandemic, there will be a significant gap betwe...
Through its Global Action Plan for Influenza Vaccines (GAP), the World Health Organization (WHO) in ...
AbstractThe Institute of Vaccines and Medical Biologicals (IVAC), a state-owned vaccine manufacturer...
AbstractThrough its Global Action Plan for Influenza Vaccines (GAP), the World Health Organization (...
AbstractIn 2005, a year after highly pathogenic avian influenza outbreaks in Thailand, the Thai Gove...
In case of an influenza pandemic, the world will be in a situation where potential vaccine supply wi...
AbstractOne of the aims of the WHO Global Action Plan for Influenza Vaccines (GAP) was to transfer i...
The international use of Influenza vaccine is growing especially in developing countries. Since 1997...
Vaccines have significantly reduced the detrimental effects of numerous human infectious diseases wo...
AbstractSince 2008, the World Health Organization has provided seed grants to 11 manufacturers in lo...
AbstractTechnology transfer is a promising approach to increase vaccine production at an affordable ...
Since 2005, the Government of the United States of America has provided more than US$ 50 million to ...
AbstractSince 2005, the Government of the United States of America has provided more than US$ 50 mil...
AbstractShould a highly pathogenic avian influenza virus, such as the H5N1 virus type currently circ...
It is predicted that in case of an influenza pandemic, there will be a significant gap between poten...
AbstractIt is predicted that in case of an influenza pandemic, there will be a significant gap betwe...
Through its Global Action Plan for Influenza Vaccines (GAP), the World Health Organization (WHO) in ...
AbstractThe Institute of Vaccines and Medical Biologicals (IVAC), a state-owned vaccine manufacturer...
AbstractThrough its Global Action Plan for Influenza Vaccines (GAP), the World Health Organization (...
AbstractIn 2005, a year after highly pathogenic avian influenza outbreaks in Thailand, the Thai Gove...
In case of an influenza pandemic, the world will be in a situation where potential vaccine supply wi...
AbstractOne of the aims of the WHO Global Action Plan for Influenza Vaccines (GAP) was to transfer i...
The international use of Influenza vaccine is growing especially in developing countries. Since 1997...
Vaccines have significantly reduced the detrimental effects of numerous human infectious diseases wo...
AbstractSince 2008, the World Health Organization has provided seed grants to 11 manufacturers in lo...
AbstractTechnology transfer is a promising approach to increase vaccine production at an affordable ...